Mostrar el registro sencillo del ítem

dc.contributor.author
Nanitsos, Ellas K.  
dc.contributor.author
Acosta, Gabriela Beatriz  
dc.contributor.author
Saihara, Yukiko  
dc.contributor.author
Stanton, David  
dc.contributor.author
Liao, Lee P.  
dc.contributor.author
Shin, Jae W.  
dc.contributor.author
Rae, Caroline  
dc.contributor.author
Balcar, Vladimir J.  
dc.date.available
2020-01-08T22:02:47Z  
dc.date.issued
2004-11  
dc.identifier.citation
Nanitsos, Ellas K.; Acosta, Gabriela Beatriz; Saihara, Yukiko; Stanton, David; Liao, Lee P.; et al.; Effects of glutamate transport substrates and glutamate receptor ligands on the activity of Na+/K+-ATPase in brain tissue in vitro; Wiley Blackwell Publishing, Inc; Clinical and Experimental Pharmacology and Physiology; 31; 11; 11-2004; 762-769  
dc.identifier.issn
0305-1870  
dc.identifier.uri
http://hdl.handle.net/11336/94087  
dc.description.abstract
1. It has been suggested that Na+/K+-ATPase and Na+-dependent glutamate transport (GluT) are tightly linked in brain tissue. In the present study, we have investigated Na+/K +-ATPase activity using Rb+ uptake by 'minislices' (prisms) of the cerebral cortex. This preparation preserves the morphology of neurons, synapses and astrocytes and is known to possess potent GluT that has been well characterized. Uptake of Rb+ was determined by estimating Rb+ in aqueous extracts of the minislices, using atomic absorption spectroscopy. 2. We determined the potencies of several known substrates/inhibitors of GluT, such as L-trans-pyrrolidine-2,4-dicarboxylate (LtPDC), DL-threo-3-benzyloxyaspartic acid, (2S,3S,4R)-2-(carboxycyclopropyl)- glycine (L-CCG III) and L-anti,endo-3,4-methanopyrrolidine dicarboxylic acid, as inhibitors of [3H]-L-glutamate uptake by cortical prisms. In addition, we established the susceptibility of GluT, measured as [ 3H]-L-glutamate uptake in brain cortical prisms, to the inhibition of Na+/K+-ATPase by ouabain. Then, we tested the hypothesis that the Na+/K+-ATPase (measured as Rb+ uptake) can respond to changes in the activity of GluT produced by using GluT substrates as GluT-specific pharmacological tools. 3. The Na+/K +-ATPase inhibitor ouabain completely blocked Rb+ uptake (IC50 = 17 μmol/L), but it also potently inhibited a fraction of GluT (approximately 50% of [3H]-L-glutamate uptake was eliminated; IC50 < 1 μmol/L). 4. None of the most commonly used GluT substrates and inhibitors, such as L-aspartate, D-aspartate, L-CCG III and LtPDC (all at 500 μmol/L), produced any significant changes in Rb+ uptake. 5. The N-methyl-D-aspartate (NMDA) receptor agonists (R,S)-(tetrazol-5-yl)-glycine and NMDA decreased Rb+ uptake in a manner compatible with their known neurotoxic actions. 6. None of the agonists or antagonists for any of the other major classes of glutamate receptors caused significant changes in Rb+ uptake. 7. We conclude that, even if a subpopulation of glutamate transporters in the rat cerebral cortex may be intimately linked to a fraction of Na+/K+-ATPase, it is not possible, under the present experimental conditions, to detect regulation of Na+/K+-ATPase by GluT.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Wiley Blackwell Publishing, Inc  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
BRAIN ENERGY METABOLISM  
dc.subject
EXCITATORY AMINO ACID TRANSPORTER SUBSTRATES AND INHIBITORS  
dc.subject
NA+ AND K+-DEPENDENT TRANSPORT OF L-GLUTAMATE  
dc.subject
NA+/K+-ATPASE  
dc.subject
RB+ UPTAKE  
dc.subject.classification
Farmacología y Farmacia  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Effects of glutamate transport substrates and glutamate receptor ligands on the activity of Na+/K+-ATPase in brain tissue in vitro  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2019-11-25T17:47:12Z  
dc.journal.volume
31  
dc.journal.number
11  
dc.journal.pagination
762-769  
dc.journal.pais
Reino Unido  
dc.journal.ciudad
Londres  
dc.description.fil
Fil: Acosta, Gabriela Beatriz. ININFA; Argentina  
dc.journal.title
Clinical and Experimental Pharmacology and Physiology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/full/10.1111/j.1440-1681.2004.04090.x?sid=nlm%3Apubmed  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1111/j.1440-1681.2004.04090.x